Analysis of eye and eyelid growths using advanced imaging technology
Analysis of Videodermatoscopic Parameters of Ocular, Periocular, Conjunctival and Palpebral Neoformations
This study is testing a new imaging technique to help doctors better understand and identify different types of growths on the eyes and eyelids, so they can tell which ones are harmless and which ones might need treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06714799 on ClinicalTrials.gov |
What this trial studies
This study focuses on the detailed examination of ocular, periocular, conjunctival, and eyelid neoformations using videodermatoscopy. By evaluating parameters such as size, shape, color, and internal structure, the study aims to differentiate between benign and potentially harmful lesions. The observational approach allows for a comprehensive assessment of these growths without the need for invasive procedures. The findings could lead to improved diagnostic accuracy and treatment planning for patients with eye-related conditions.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with specific ocular and periocular conditions such as melanocytic nevus, basal cell carcinoma, and melanoma.
Not a fit: Patients with inflammatory conditions or multiple lesions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the ability to accurately diagnose and manage various eye and eyelid growths, leading to better patient outcomes.
How similar studies have performed: While the use of videodermatoscopy is established in dermatology, this specific application in ocular conditions is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients who had been diagnosed with one of the following conditions in the ocular and periocular region: common melanocytic nevus, melanosis, seborrheic keratosis, viral wart, angioma and angiokeratoma, apocrine hydrocystoma, xanthelasma, steatocystoma, actinic keratosis, basal cell carcinoma, squamous cell carcinoma, melanoma. Exclusion Criteria: * Patients who presented with one of the following conditions were excluded from the study: concomitant inflammatory processes, including blepharitis, chalazion, pterygium, pinguecula), coexistence of multiple, periocular or ocular lesions, diagnosis of syndromic diseases related to a major risk for cutaneous neoformations.
Where this trial is running
Bologna
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Sabina Vaccari, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Sabina Vaccari, MD
- Email: sabina.vaccari@aosp.bo.it
- Phone: 3403646960
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.